TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10735789

Group type: EXPERIMENTAL
Intervention: Ketamine 0.94 mg/mL
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ketamine 1.88 mg/mL
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ketamine 2.83 mg/mL
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Propofol (9.4 mg/mL) with ketamine (0.94-1.88 mg/mL)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 100
Study: 8795320

Group type: EXPERIMENTAL
Intervention: Single orifice catheters
Number of subjects: 20

Group type: COMPARATOR
Intervention: Multi-orifice catheters
Number of subjects: 20
Study: 1412652

Group type: EXPERIMENTAL
Intervention: Ivermectin (4 doses at 6-monthly intervals)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2863777

Group type: EXPERIMENTAL
Intervention: Milenperone (2 X 5 mg daily for the first 3 weeks, then 2 X 10 mg daily for the following 3 weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Milenperone (2 X 10 mg daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Milenperone
Number of subjects: 20
Study: 30765235

Group type: EXPERIMENTAL
Intervention: Conventional circumferential supracrestal fiberotomy (CSF)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser‐aided circumferential supracrestal fiberotomy (CSF)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Probing depth
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Clinical crown height
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Pain levels
Number of subjects: 46
Study: 25477057

Group type: EXPERIMENTAL
Intervention: Education by ultrasonography (US) feedback
Number of subjects: 95

Group type: COMPARATOR
Intervention: Standard care without education
Number of subjects: 95
Study: 25558638

Group type: EXPERIMENTAL
Intervention: McGrath Series 5 video laryngoscope
Number of subjects: 80

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 80
Study: 22479542

Group type: EXPERIMENTAL
Intervention: Recombinant Ad5 HIV-1 gag vaccine
Number of subjects: 104
Study: 19375704

Group type: EXPERIMENTAL
Intervention: Oral misoprostol (50 microg, 4-hourly, up to 3 doses)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Intracervical PGE2 gel (2 applications at 6-hour interval)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Oral misoprostol
Number of subjects: 61

Group type: COMPARATOR
Intervention: Intracervical PGE2 gel
Number of subjects: 61
Study: 17487535

Group type: EXPERIMENTAL
Intervention: 8-week pulmonary rehabilitation program (exercise plus education)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study: 15247492

Group type: EXPERIMENTAL
Intervention: Double-step PCR assay for quantification of Epstein-Barr virus (EBV) DNA in peripheral blood.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semiquantitative PCR assay followed by quantitative-competitive (QC)-PCR assay.
Number of subjects: 0
Study: 11290990

Group type: EXPERIMENTAL
Intervention: Soothing music and low noise levels in the PACU (experimental group)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Typical PACU environment (control group)
Number of subjects: 97
Study: 9569434

Group type: EXPERIMENTAL
Intervention: Amoxycillin
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Penicillin V
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 8626081

Group type: EXPERIMENTAL
Intervention: SLO perimetry
Number of subjects: 50

Group type: COMPARATOR
Intervention: Octopus 500 (program 38)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Comparison of SLO and Octopus
Number of subjects: 50
Study: 2666736

Group type: EXPERIMENTAL
Intervention: cordiamine
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: phenobarbital
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: ziscorine
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: phenobarbital and pyrogenal combination
Number of subjects: 48
Study: 785959

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (3 to 1.5 mg/kg b.wt. for 4 months)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 50
Study: 31646339

Group type: EXPERIMENTAL
Intervention: Supervised exercise (n = 38)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Wait-list usual care (n = 18)
Number of subjects: 54
Study: 31255386

Group type: EXPERIMENTAL
Intervention: Infants with LPE treated before day 6
Number of subjects: 137

Group type: COMPARATOR
Intervention: Enrolled infants in the PDA-TOLERATE trial
Number of subjects: 137
Study: 28632467

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) combined with functional training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 20
Study: 26202439

Group type: EXPERIMENTAL
Intervention: New Nordic Diet (NND) school meals
Number of subjects: 834

Group type: COMPARATOR
Intervention: Usual packed lunches (control)
Number of subjects: 834
Study: 23536769

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AER)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Combined exercise (COMB)
Number of subjects: 14
Study: 21610429

Group type: EXPERIMENTAL
Intervention: Brachioradialis rSO2 measurements in ICU septic shock patients
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Lactate concentration in ICU septic shock patients
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cardiac index in ICU septic shock patients
Number of subjects: 19
Study: 20137542

Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg/day)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg/day)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Telmisartan (80 mg/day)
Number of subjects: 102
Study: 16621226

Group type: COMPARATOR
Intervention: Hydralazine (5 mg as a slow bolus dose given intravenously, repeated every 20 min up to a maximum of five doses)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Labetalol (20‐mg intravenous bolus dose followed by 40 mg if not effective within 20 min, followed by 80 mg every 20 min up to a maximum dose of 300 mg)
Number of subjects: 200
Study: 15137563

Group type: EXPERIMENTAL
Intervention: Seating Identification Tool (SIT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Formal evaluation by a therapist
Number of subjects: 42
Study: 11375358

Group type: EXPERIMENTAL
Intervention: Miglitol plus Metformin
Number of subjects: 324

Group type: COMPARATOR
Intervention: Metformin alone
Number of subjects: 324
Study: 9423902

Group type: EXPERIMENTAL
Intervention: Corticosteroids (fluorometholone 0.1%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diclofenac sodium 0.1% (Decrol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Flurbiprofen sodium 0.03% (Ocufen)
Number of subjects: 0

Group type: COMPARATOR
Intervention: NSAID subgroups (Flurbiprofen and Diclofenac)
Number of subjects: 0
Study: 8274583

Group type: EXPERIMENTAL
Intervention: Yohimbine infusion
Number of subjects: 29

Group type: COMPARATOR
Intervention: Normal saline infusion (Control)
Number of subjects: 29
Study: 6134093

Group type: EXPERIMENTAL
Intervention: Birth chair
Number of subjects: 189

Group type: COMPARATOR
Intervention: Conventional dorsal position
Number of subjects: 189
Study: 30697688

Group type: COMPARATOR
Intervention: Low volume interscalene block using 5 mL of ropivacaine 0.5% (LVS group)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Infraclavicular-subomohyoid block using 25 mL of ropivacaine 0.5% (ISO group)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Low volume interscalene block (LVS group)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Infraclavicular-subomohyoid block (ISO group)
Number of subjects: 72
Study: 28376674

Group type: EXPERIMENTAL
Intervention: Whole body vibration training (WBVT) for 6 weeks, 3 sessions per week
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 33
Study: 26895715

Group type: EXPERIMENTAL
Intervention: Prehospital fast track care (PFTC)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Traditional care pathway (A&E group)
Number of subjects: 400
Study: 25571679

Group type: EXPERIMENTAL
Intervention: CPP‐ACP cream (Tooth Mousse, GC Europe N.V., Leuven, Belgium)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fluoride containing toothpaste
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (CPP‐ACP and control)
Number of subjects: 60
Study: 22698005

Group type: EXPERIMENTAL
Intervention: Retroperitoneal laparoscopic radical nephrectomy (n=31)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Open radical nephrectomy (n=31)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 62
Study: 19328538

Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg daily
Number of subjects: 18882

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18882
Study: 17327342

Group type: EXPERIMENTAL
Intervention: NOS3 ‐786T‐‐>C genotype
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Glu298Glu genotype
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Univariate analysis including age, sex, BMI percentile, and ‐786T‐‐>C genotype
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Multivariate model including age, sex, BMI percentile, and ‐786T‐‐>C genotype
Number of subjects: 36
Study: 16469616

Group type: EXPERIMENTAL
Intervention: Microsurgical approach using isosulfan blue
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard microsurgery
Number of subjects: 50
Study: 15467218

Group type: EXPERIMENTAL
Intervention: Sho-hange-ka-bukuryo-to
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10391259

Group type: EXPERIMENTAL
Intervention: Ministernotomy (group M)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Median sternotomy (group S)
Number of subjects: 40
Study: 8913975

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Lactated Ringer's solution
Number of subjects: 67
Study: 1678760

Group type: EXPERIMENTAL
Intervention: 4% chlorhexidine (CHX)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 6837786

Group type: EXPERIMENTAL
Intervention: Bilateral ECT (N = 24)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Unilateral ECT (N = 27)
Number of subjects: 51
Study: 31440799

Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA radioligand therapy (PSMA-RLT)
Number of subjects: 0
Study: 28892656

Group type: EXPERIMENTAL
Intervention: rt-PA treatment group
Number of subjects: 40

Group type: COMPARATOR
Intervention: non-rt-PA treatment group
Number of subjects: 40
Study: 25789421

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (NMB) at 12 mmHg pneumoperitoneum
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (NMB) at 8 mmHg pneumoperitoneum
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (NMB) during suturing
Number of subjects: 14
Study: 23666681

Group type: EXPERIMENTAL
Intervention: NT‐proBNP‐guided therapy
Number of subjects: 495

Group type: COMPARATOR
Intervention: Symptom-guided therapy
Number of subjects: 495
Study: 21729014

Group type: EXPERIMENTAL
Intervention: Bringing Baby Home psycho‐educational intervention
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Workshop prebirth
Number of subjects: 181

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Workshop
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Workshop plus support group
Number of subjects: 181
Study: 18504059

Group type: EXPERIMENTAL
Intervention: Bipolar Collaborative Chronic Care Model (B-CCM)
Number of subjects: 290

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 290
Study: 16472720

Group type: EXPERIMENTAL
Intervention: Misleading cue indicating the taste would be mildly aversive
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Functional connectivity among the OFC, rACC, and insula
Number of subjects: 0
Study: 15014005

Group type: EXPERIMENTAL
Intervention: Ketorolac (10 ml of a 0.1% ketorolac rinse solution; n = 38)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo (10 ml of rinse solution; n = 19)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Ketorolac
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 11053335

Group type: EXPERIMENTAL
Intervention: High-glycemic index (HGI) meal
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Low-glycemic index (LGI) meal
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (Con) meal
Number of subjects: 8
Study: 9326833

Group type: EXPERIMENTAL
Intervention: Valproate plus lithium
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Triple therapy (lithium, carbamazepine, and valproate)
Number of subjects: 24
Study: 8463765

Group type: EXPERIMENTAL
Intervention: Smoking (one cigarette per hour for 6 h)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Snuffing (one bag‐packed snuff per hour for 6 h)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (refrained from nicotine for 48 h)
Number of subjects: 7
Study: 3979291

Group type: EXPERIMENTAL
Intervention: Immunoglobulin administration (0.25 g/kg body weight)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (no immunoglobulin)
Number of subjects: 180
Study: 31390883

Group type: EXPERIMENTAL
Intervention: Volanesorsen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29725828

Group type: EXPERIMENTAL
Intervention: iv dexmedetomidine 0.5 mcg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: iv lidocaine 2 mg/kg
Number of subjects: 60
Study: 26228699

Group type: EXPERIMENTAL
Intervention: Adhesion barrier applied
Number of subjects: 42

Group type: COMPARATOR
Intervention: No adhesion barrier applied
Number of subjects: 42
Study: 24647393

Group type: EXPERIMENTAL
Intervention: Increased dietary phylloquinone intake
Number of subjects: 7216

Group type: EXPERIMENTAL
Intervention: Increased dietary menaquinone intake
Number of subjects: 7216

Group type: EXPERIMENTAL
Intervention: Changes in menaquinone intake
Number of subjects: 7216
Study: 23167296

Group type: EXPERIMENTAL
Intervention: Standard 3‐day bowel preparation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Only over‐night fasting before surgery
Number of subjects: 40
Study: 20103303

Group type: EXPERIMENTAL
Intervention: Preoperative thoracic epidural analgesia (TEA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Postoperative thoracic epidural analgesia (TEA)
Number of subjects: 40
Study: 18594088

Group type: EXPERIMENTAL
Intervention: Collagen meniscus implant
Number of subjects: 311

Group type: COMPARATOR
Intervention: Partial meniscectomy
Number of subjects: 311
Study: 15964200

Group type: EXPERIMENTAL
Intervention: 500 mL of a commercial red beet juice (RBJ) containing 362.7 mg of betalains
Number of subjects: 6

Group type: COMPARATOR
Intervention: 500 mL of tap water
Number of subjects: 6
Study: 11814217

Group type: EXPERIMENTAL
Intervention: Monolog condition
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Dialog condition
Number of subjects: 163

Group type: COMPARATOR
Intervention: Communicative context
Number of subjects: 163

Group type: COMPARATOR
Intervention: Individual characteristics of the speaker
Number of subjects: 163
Study: 9712921

Group type: EXPERIMENTAL
Intervention: Lubeluzole 5 mg (loading dose 3.75 mg over 1 h)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Lubeluzole 10 mg (loading dose 7.5 mg over 1 h)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 7978399

Group type: EXPERIMENTAL
Intervention: Desflurane-based general anesthetic technique
Number of subjects: 50

Group type: COMPARATOR
Intervention: Propofol-based general anesthetic technique
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (Desflurane and Propofol)
Number of subjects: 50
Study: 2500688

Group type: EXPERIMENTAL
Intervention: 20 mg disodium cromoglycate (DSCG) four times daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 5015036

Group type: EXPERIMENTAL
Intervention: L‐alpha‐methyldopahydrazine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Levodopa without L‐alpha‐methyldopahydrazine
Number of subjects: 20
Study: 30982849

Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg bid
Number of subjects: 635

Group type: COMPARATOR
Intervention: Warfarin (INR-adjusted)
Number of subjects: 635

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 635

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 635
Study: 29145468

Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy (scaling and root planing plus oral hygiene instructions, and supportive therapy at 3 and 6 months)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (oral hygiene instructions only)
Number of subjects: 40
Study: 25100386

Group type: EXPERIMENTAL
Intervention: Sensor-augmented pump (SAP) therapy
Number of subjects: 485

Group type: COMPARATOR
Intervention: Multiple daily injections (MDI) therapy
Number of subjects: 485
Study: 24050864

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography (TEE)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Transthoracic echocardiography (TTE)
Number of subjects: 40

Group type: COMPARATOR
Intervention: TTE
Number of subjects: 40
Study: 21478329

Group type: EXPERIMENTAL
Intervention: Sliding scale regular insulin
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Weight-based regimen
Number of subjects: 3000
Study: 17544528

Group type: EXPERIMENTAL
Intervention: Coronary stenting
Number of subjects: 6922
Study: 17156181

Group type: COMPARATOR
Intervention: BDI ≥ 10
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: BDI < 10
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Low level of problem focusing and social support seeking
Number of subjects: 600
Study: 12755932

Group type: EXPERIMENTAL
Intervention: Detergent-coated spacers (CG)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non-coated spacers (NCG)
Number of subjects: 50
Study: 10629456

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation and high-efficiency vacuum cleaner (HEVC)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation alone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High-efficiency vacuum cleaner (HEVC) alone
Number of subjects: 40

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation and HEVC
Number of subjects: 40
Study: 8803526

Group type: EXPERIMENTAL
Intervention: Diprafenone administered with food (100 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Diprafenone administered in fasting state (100 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Slow hydroxylator of debrisoquine (100 mg with food)
Number of subjects: 15
Study: 1323615

Group type: EXPERIMENTAL
Intervention: Stavudine (d4T) at doses of 0.67, 1.33, 2.67, or 4 mg/kg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Stavudine (d4T) after chronic dosing
Number of subjects: 22
Study: 6387568

Group type: EXPERIMENTAL
Intervention: Topical .03% sodium flurbiprofen
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Topical 1% indomethacin
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (for indomethacin protocol)
Number of subjects: 70
Study: 29247042

Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol
Number of subjects: 87

Group type: COMPARATOR
Intervention: Oral paracetamol
Number of subjects: 87
Study: 26779816

Group type: EXPERIMENTAL
Intervention: MOTIV (45 min adaptation of motivational interviewing)
Number of subjects: 351

Group type: COMPARATOR
Intervention: BNI (15 min Brief Negotiated Interview)
Number of subjects: 351
Study: 24424781

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 23340006

Group type: EXPERIMENTAL
Intervention: Breakfast consumption (1859 kJ) followed by rest (BR)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Breakfast consumption followed by exercise (BE)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Exercise without breakfast (FE)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Rest without breakfast (FR)
Number of subjects: 12
Study: 20532194

Group type: EXPERIMENTAL
Intervention: Peer health workers (PHW) intervention
Number of subjects: 1336

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1336
Study: 18405148

Group type: EXPERIMENTAL
Intervention: Aconite cake‐separated moxibustion
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sodium Diclofenate Slow‐released Tablet
Number of subjects: 56
Study: 17087785

Group type: EXPERIMENTAL
Intervention: Nedocromil
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Aminoguanidine
Number of subjects: 15
Study: 12800105

Group type: EXPERIMENTAL
Intervention: Functional oil (FctO) composed of medium chain triacylglycerols (50% of fat), phytosterols (22 mg/kg body weight), and n-3 fatty acids (5% of fat)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Functional oil (FctO)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Beef tallow (BT)
Number of subjects: 17
Study: 10536550

Group type: EXPERIMENTAL
Intervention: Riluzole 100 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8906050

Group type: EXPERIMENTAL
Intervention: Superpulsed CO2 laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cryotherapy and superpulsed CO2 laser
Number of subjects: 20
Study: 1809619

Group type: EXPERIMENTAL
Intervention: Intracoronary streptokinase 250,000 IU followed by intravenous heparin along with conventional treatment
Number of subjects: 67

Group type: COMPARATOR
Intervention: Conventional treatment alone
Number of subjects: 67
Study: 6406037

Group type: COMPARATOR
Intervention: RT (extended field radiotherapy)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: RT + CT (radiotherapy plus adjuvant chemotherapy with vincristine, streptonigrin, cyclophosphamide and prednisone)
Number of subjects: 73

Group type: COMPARATOR
Intervention: RT
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: RT + CT
Number of subjects: 73

Group type: COMPARATOR
Intervention: RT (among patients with unfavorable histology)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: RT + CT (among patients with unfavorable histology)
Number of subjects: 73